Status:
COMPLETED
Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery
Lead Sponsor:
Sanofi
Conditions:
Hip Fractures
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.
Eligibility Criteria
Inclusion
- femoral neck inside or outside fracture
Exclusion
- any major surgery on lower limbs within 3 months
- clinical signs of deep vein thrombosis
- use of non-steroidal anti-inflammatory drugs
- severe hepatic disease or renal insufficiency
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00685958
Start Date
July 1 2006
End Date
March 1 2007
Last Update
October 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi- Aventis Administrative Office
Tokyo, Japan